These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 1673407
21. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine. Szymura-Oleksiak J, Panas M, Chruściel W. Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958 [Abstract] [Full Text] [Related]
22. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression]. Szymura-Oleksiak J, Wasieczko A. Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375 [Abstract] [Full Text] [Related]
23. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J. Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212 [Abstract] [Full Text] [Related]
24. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine. DeVane CL, Jusko WJ. Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042 [Abstract] [Full Text] [Related]
26. Effects of recombinant drug-specific single chain antibody Fv fragment on [3H]-desipramine distribution in rats. Shelver WL, Keyler DE, Lin G, Murtaugh MP, Flickinger MC, Ross CA, Pentel PR. Biochem Pharmacol; 1996 Feb 23; 51(4):531-7. PubMed ID: 8619899 [Abstract] [Full Text] [Related]
27. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi Y, Igarashi S, Suzuki T, Horie T, Narimatsu S. J Pharmacol Exp Ther; 1996 Nov 23; 279(2):724-31. PubMed ID: 8930177 [Abstract] [Full Text] [Related]
28. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. Gordon JT, Tomlinson EE, Greenberg J, Dratman MB. J Pharmacol Exp Ther; 1994 Jul 23; 270(1):111-7. PubMed ID: 8035306 [Abstract] [Full Text] [Related]
30. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats. Pentel PR, Keyler DE. J Pharmacol Exp Ther; 1988 Sep 23; 246(3):1061-6. PubMed ID: 3418509 [Abstract] [Full Text] [Related]
31. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring]. Szymura-Oleksiak J, Wasieczko A, Wyska E, Zieba A. Psychiatr Pol; 1994 Sep 23; 28(1):17-26. PubMed ID: 8190816 [Abstract] [Full Text] [Related]
36. Estrogens participate in the antidepressant-like effect of desipramine and fluoxetine in male rats. Martínez-Mota L, Cruz-Martínez JJ, Márquez-Baltazar S, Fernández-Guasti A. Pharmacol Biochem Behav; 2008 Jan 23; 88(3):332-40. PubMed ID: 17915301 [Abstract] [Full Text] [Related]
37. Chronic administration of desipramine and imipramine but not zimelidine attenuates clonidine-induced depression of avoidance behavior in rats. Kostowski W, Obersztyn M. Pol J Pharmacol Pharm; 1988 Jan 23; 40(4):341-9. PubMed ID: 2851779 [Abstract] [Full Text] [Related]
39. Evaluation of the potential of surface enhancement Raman spectroscopy for detection of tricyclic psychotropic drugs. Case studies on imipramine and its metabolite. Jaworska A, Wietecha-Posłuszny R, Woźniakiewicz M, Kościelniak P, Malek K. Analyst; 2011 Nov 21; 136(22):4704-9. PubMed ID: 21961110 [Abstract] [Full Text] [Related]
40. Distribution interactions between perazine and antidepressant drugs. In vivo studies. Wójcikowski J, Daniel WA. Pol J Pharmacol; 2000 Nov 21; 52(6):449-57. PubMed ID: 11334238 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]